Bartalena L, Bogazzi F, Brogioni S, Burelli A, Scarcello G, Martino E
Istituto di Endocrinologia, University of Pisa, Italy.
Horm Res. 1996;45(3-5):142-7. doi: 10.1159/000184777.
Free thyroid hormones (free thyroxine, FT4, and free triiodothyronine, FT3) represent a more useful index of thyroid status than total thyroid hormones, because the latter are influenced by variations of thyroid hormone-binding proteins, especially T4-binding globulin (TBG). Thus, increased serum total T4 (TT4) and, in many instances, T3 (TT3) concentrations are encountered in euthyroid subjects with TBG excess, familial dysalbuminemic hyperthyroxinemia and transthyretin-associated hyperthyroxinemia, while decreased serum TT4 and TT3 levels are associated with TBG deficiency: under these circumstances, measurement of serum FT4 and FT3 levels correctly establishes the diagnosis of euthyroidism. In cases of suspected hyperthyroidism, a diagnostic strategy can be suggested based on serum FT3 (and TSH) measurement, since FT4 may occasionally be elevated, also in euthyroid subjects, e.g., in patients under chronic amiodarone or L-T4 treatment. When hypothyroidism is suspected, the most reliable test appears to be FT4 (together with TSH), because FT3 may still be normal in patients with subclinical or mild thyroid failure. In any case, it is essential that reliable free thyroid hormone assays be used, which are devoid of methodological limitations responsible for artifactual results under particular circumstances, such as thyroid hormone-binding protein abnormalities, pregnancy and nonthyroidal illness.
游离甲状腺激素(游离甲状腺素,FT4,和游离三碘甲状腺原氨酸,FT3)比总甲状腺激素更能反映甲状腺状态,因为总甲状腺激素受甲状腺激素结合蛋白,尤其是甲状腺素结合球蛋白(TBG)变化的影响。因此,在TBG增多、家族性白蛋白异常性高甲状腺素血症和转甲状腺素蛋白相关高甲状腺素血症的甲状腺功能正常患者中,血清总T4(TT4)浓度升高,在许多情况下,T3(TT3)浓度也升高,而血清TT4和TT3水平降低与TBG缺乏有关:在这些情况下,测定血清FT4和FT3水平可正确诊断甲状腺功能正常。在疑似甲状腺功能亢进的病例中,可根据血清FT3(和TSH)测量结果提出诊断策略,因为在甲状腺功能正常的患者中,如接受慢性胺碘酮或L-T4治疗的患者,FT4偶尔也可能升高。当怀疑甲状腺功能减退时,最可靠的检查似乎是FT4(连同TSH),因为在亚临床或轻度甲状腺功能减退的患者中,FT3可能仍正常。无论如何,使用可靠的游离甲状腺激素测定方法至关重要,这些方法不存在在特定情况下导致人为结果的方法学局限性,如甲状腺激素结合蛋白异常、妊娠和非甲状腺疾病。